Staab Thomas R II
Tenax Therapeutics, Inc. · Chief Financial Officer
Staab Thomas R II is listed in public filings as officer: Chief Financial Officer. This Staab Thomas R II insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Tenax Therapeutics, Inc. (TENX), and LENSAR, Inc. (LNSR). Investors use Staab Thomas R II's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $5.4M450k shares | Grant / ExerciseMay 11, 2026 | $5.4M450k shares | $11.95 | -- | |
| --10k shares | Grant / ExerciseMay 11, 2026 | Disclosure amount unavailable10k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $940k174.6k shares | Grant / ExerciseMay 6, 2026 | $7.3K1.4k shares | $5.39 | -- | |
| $38k14.3k shares | Grant / ExerciseMar 19, 2026 | $14.6K5.5k shares | $2.65 | -- | |
| $1.9M170.5k shares | Grant / ExerciseFeb 18, 2026 | $12.2K1.1k shares | $11.32 | -- | |
| $2.0M171.5k shares | Grant / ExerciseJan 11, 2026 | $21.1K1.8k shares | $11.57 | -- | |
| --173.4k shares | Grant / ExerciseFeb 18, 2025 | Disclosure amount unavailable12.8k shares | -- | -- | |
| $1.3M160.6k shares | Grant / ExerciseJan 11, 2025 | $15.2K1.8k shares | $8.25 | -- | |
| $52k19.8k shares | Grant / ExerciseAug 8, 2024 | $9.3K3.5k shares | $2.65 | -- |